Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Pruvanserin
Другие языки:

    Pruvanserin

    Подписчиков: 0, рейтинг: 0
    Pruvanserin
    Pruvanserin.png
    Clinical data
    Routes of
    administration
    Oral
    ATC code
    • none
    Legal status
    Legal status
    • In general: uncontrolled
    Identifiers
    • 7-({4-[2-(4-fluorophenyl)ethyl]piperazin-1-yl}carbonyl)-1H-indole-3-carbonitrile
    CAS Number
    PubChem CID
    ChemSpider
    UNII
    ChEMBL
    CompTox Dashboard (EPA)
    Chemical and physical data
    Formula C22H21FN4O
    Molar mass 376.435 g·mol−1
    3D model (JSmol)
    • N#Cc2c1cccc(c1[nH]c2)C(=O)N4CCN(CCc3ccc(F)cc3)CC4

    Pruvanserin (EMD-281,014, LY-2,422,347) is a selective 5-HT2A receptor antagonist which was under development by Eli Lilly and Company for the treatment of insomnia. It was in phase II clinical trials in 2008 but appears to have been discontinued as it is no longer in the company's development pipeline. In addition to its sleep-improving properties, pruvanserin has also been shown to have antidepressant, anxiolytic, and working memory-enhancing effects in animal studies.

    See also


    Новое сообщение